These studies suggest that NURR1 protects from the loss of mDA in dopamine-associated brain disorders, such as Parkinson’s disease (PD), in part by limiting the production of neurotoxic mediators by microglia and astrocytes. Here, NR4A2 is linked to brain disorder.